79333739 - IMMUDEX

Information

• Trademark
• 79333739

• Source

• Serial Number

  79333739

• Registration Number

  7282161

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 10, 2021
  4 years ago

• Registration Date

  January 23, 2024
  2 years ago

• Transaction Date

  November 19, 2024
  a year ago

• Status Date

  January 23, 2024
  2 years ago

• Published for Opposition Date

  November 07, 2023
  2 years ago

• Location Date

  January 23, 2024
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ALLEN, BIANCA

• Attorney Docket Number

  6084IM-2

  Attorney Name

  Miriam D. Trudell

  Law Office Assigned Location Code

  N50

• Owners

  • Immudex ApS

Case File Statements

• DM0000: The mark consists of the stylized wording "IMMUDEX" wherein the letters are colored blue, and the dot of the letter "I" is colored orange.
• GS0051: Preparations for pharmaceutical purposes, namely, pharmaceutical preparations for the treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes, namely, diagnostic preparations for medical purposes and medical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T- cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; vaccines; diagnostic preparations for analysis for medical purposes, hereunder for each of the abovementioned preparations for medical analysis of vaccines, immunotherapeutics and cellular therapies, in particular cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV- vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy or other therapy, for medical analysis and treatment of T- cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases; diagnostic preparations for analysis for medical purposes, hereunder for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring
• CC0000: The color(s) blue and orange is/are claimed as a feature of the mark.
• GS0011: Chemicals used in industry and science, in the nature of immune related chemicals for immune cell analysis, immune cell monitoring, immune cell detection and immune cell stimulation and immune related chemicals used in science in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; diagnostic reagents for diagnostic being research use, other than medical and veterinary use, and scientific use; research diagnostic reagents for scientific use; diagnostic test materials for scientific and diagnostic, other than medical and veterinary, purposes, namely, diagnostic reagents and preparations, except for medical or veterinary use; diagnostic kits for scientific and diagnostic, other than medical and veterinary, purposes comprised of diagnostic reagents and preparations, except for medical or veterinary use and also comprised of immune related chemicals used in science, in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; assays for research purposes; biochemical reagents for non- medical purposes, other than medical and veterinary; chemical and diagnostic preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB- vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for use in scientific research in connection with therapy and immunotherapy, in particular, for use in cancer therapy, cancer immunotherapy, for analysis of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; chemical, and diagnostic preparations for analysis for research purposes related to analysis of infectious diseases, autoimmunity and for use in scientific research in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes
• GS0421: Scientific and technological services, namely, scientific research, analysis and testing in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific research; scientific research services, namely, diagnostic services related to research; analysis of medicine, pharmaceuticals and vaccines of others to assure compliance with industry standards; industrial research services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; basic scientific research and clinical scientific research, hereunder for medicine and vaccine development; product research and development in the field of diagnostic preparations

Case File Event Statements

• 2/17/2022 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 2/22/2022 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/26/2022 - 3 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 8/24/2022 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 9/1/2022 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/2/2022 - 3 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 10/27/2022 - 3 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 10/27/2022 - 3 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 11/14/2022 - 3 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 4/2/2023 - 2 years ago

  10 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 4/27/2023 - 2 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/27/2023 - 2 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/3/2023 - 2 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/5/2023 - 2 years ago

  14 - ASSIGNED TO EXAMINER Type: DOCK

• 7/6/2023 - 2 years ago

  15 - FINAL REFUSAL WRITTEN Type: CNFR

• 7/6/2023 - 2 years ago

  16 - FINAL REFUSAL E-MAILED Type: GNFR

• 7/6/2023 - 2 years ago

  17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 7/19/2023 - 2 years ago

  18 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 7/19/2023 - 2 years ago

  19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 8/6/2023 - 2 years ago

  20 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 10/4/2023 - 2 years ago

  21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 10/4/2023 - 2 years ago

  22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/4/2023 - 2 years ago

  23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/5/2023 - 2 years ago

  24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/18/2023 - 2 years ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/18/2023 - 2 years ago

  27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 10/18/2023 - 2 years ago

  26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 11/6/2023 - 2 years ago

  28 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 11/7/2023 - 2 years ago

  29 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/7/2023 - 2 years ago

  30 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/23/2024 - 2 years ago

  31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 4/23/2024 - a year ago

  34 - FINAL DISPOSITION PROCESSED Type: FIMP

• 5/13/2024 - a year ago

  36 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 11/13/2024 - a year ago

  39 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 11/13/2024 - a year ago

  38 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 11/13/2024 - a year ago

  37 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/24/2024 - a year ago

  35 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 1/23/2024 - 2 years ago

  32 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 4/23/2024 - a year ago

  33 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR